# Ketorolac in Acute Pancreatitis

> **NCT04282200** · PHASE4 · UNKNOWN · sponsor: **University of Cincinnati** · enrollment: 60 (estimated)

## Conditions studied

- Acute Pancreatitis

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT04282200
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-24
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04282200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04282200, "Ketorolac in Acute Pancreatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04282200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*